BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23670573)

  • 1. Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola.
    Shedlock DJ; Aviles J; Talbott KT; Wong G; Wu SJ; Villarreal DO; Myles DJ; Croyle MA; Yan J; Kobinger GP; Weiner DB
    Mol Ther; 2013 Jul; 21(7):1432-44. PubMed ID: 23670573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
    Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
    Front Immunol; 2021; 12():703986. PubMed ID: 34484200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
    Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
    Geisbert TW; Geisbert JB; Leung A; Daddario-DiCaprio KM; Hensley LE; Grolla A; Feldmann H
    J Virol; 2009 Jul; 83(14):7296-304. PubMed ID: 19386702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model.
    Keshwara R; Hagen KR; Abreu-Mota T; Papaneri AB; Liu D; Wirblich C; Johnson RF; Schnell MJ
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge.
    Grant-Klein RJ; Van Deusen NM; Badger CV; Hannaman D; Dupuy LC; Schmaljohn CS
    Hum Vaccin Immunother; 2012 Nov; 8(11):1703-6. PubMed ID: 22922764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses.
    Wang D; Schmaljohn AL; Raja NU; Trubey CM; Juompan LY; Luo M; Deitz SB; Yu H; Woraratanadharm J; Holman DH; Moore KM; Swain BM; Pratt WD; Dong JY
    Vaccine; 2006 Apr; 24(15):2975-86. PubMed ID: 16530297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.
    Warfield KL; Swenson DL; Negley DL; Schmaljohn AL; Aman MJ; Bavari S
    Vaccine; 2004 Sep; 22(25-26):3495-502. PubMed ID: 15308377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.
    Suschak JJ; Schmaljohn CS
    Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.
    Warfield KL; Olinger GG
    J Biomed Biotechnol; 2011; 2011():984241. PubMed ID: 22253531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation.
    Marzi A; Menicucci AR; Engelmann F; Callison J; Horne EJ; Feldmann F; Jankeel A; Feldmann H; Messaoudi I
    Front Immunol; 2018; 9():3071. PubMed ID: 30723475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
    Martins K; Carra JH; Cooper CL; Kwilas SA; Robinson CG; Shurtleff AC; Schokman RD; Kuehl KA; Wells JB; Steffens JT; van Tongeren SA; Hooper JW; Bavari S
    Viral Immunol; 2015 Feb; 28(1):62-70. PubMed ID: 25514232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates.
    Geisbert TW; Bailey M; Geisbert JB; Asiedu C; Roederer M; Grazia-Pau M; Custers J; Jahrling P; Goudsmit J; Koup R; Sullivan NJ
    J Virol; 2010 Oct; 84(19):10386-94. PubMed ID: 20660192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges.
    Wang D; Hevey M; Juompan LY; Trubey CM; Raja NU; Deitz SB; Woraratanadharm J; Luo M; Yu H; Swain BM; Moore KM; Dong JY
    Virology; 2006 Sep; 353(2):324-32. PubMed ID: 16820184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.
    Swenson DL; Wang D; Luo M; Warfield KL; Woraratanadharm J; Holman DH; Dong JY; Pratt WD
    Clin Vaccine Immunol; 2008 Mar; 15(3):460-7. PubMed ID: 18216185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in filovirus vaccine development: evaluating the potential for clinical use.
    Falzarano D; Geisbert TW; Feldmann H
    Expert Rev Vaccines; 2011 Jan; 10(1):63-77. PubMed ID: 21162622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.
    Swenson DL; Warfield KL; Larsen T; Alves DA; Coberley SS; Bavari S
    Expert Rev Vaccines; 2008 May; 7(4):417-29. PubMed ID: 18444889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of common marburgvirus protective epitopes in a BALB/c mouse model.
    Kalina WV; Warfield KL; Olinger GG; Bavari S
    Virol J; 2009 Aug; 6():132. PubMed ID: 19712478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates.
    Mire CE; Geisbert JB; Agans KN; Satterfield BA; Versteeg KM; Fritz EA; Feldmann H; Hensley LE; Geisbert TW
    PLoS One; 2014; 9(4):e94355. PubMed ID: 24759889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced antisense therapies for postexposure protection against lethal filovirus infections.
    Warren TK; Warfield KL; Wells J; Swenson DL; Donner KS; Van Tongeren SA; Garza NL; Dong L; Mourich DV; Crumley S; Nichols DK; Iversen PL; Bavari S
    Nat Med; 2010 Sep; 16(9):991-4. PubMed ID: 20729866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.